Cristiano Caruso

Rome, 00168, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Staphylococcus Aureus Toxins and Asthma: Pathophysiological Mechanisms, Clinical Relevance, and Therapeutic Implications in the Biologics Era.

Staphylococcus Aureus Toxins and Asthma: Pathophysiological Mechanisms, Clinical Relevance, and Therapeutic Implications in the Biologics Era.

Journal: Toxins

Published: July 02, 2026

Adherence to inhaled treatment is associated with better disease control and quality of life in mild-to-moderate asthma.

Adherence to inhaled treatment is associated with better disease control and quality of life in mild-to-moderate asthma.

Journal: Respiratory medicine

Published: June 16, 2026

Letter: Peripheral Blood Eosinophils as Complementary Biomarkers for Diagnosis and Follow-Up in Eosinophilic Oesophagitis.

Letter: Peripheral Blood Eosinophils as Complementary Biomarkers for Diagnosis and Follow-Up in Eosinophilic Oesophagitis.

Journal: Alimentary pharmacology & therapeutics

Published: June 05, 2026

Trajectories in Oxidative Stress and Corticosteroids Insensitivity in Patient with High Risk of Severe Asthma: Use of FeNO as Biomarker of Respiratory Epithelial Barrier Distress.

Trajectories in Oxidative Stress and Corticosteroids Insensitivity in Patient with High Risk of Severe Asthma: Use of FeNO as Biomarker of Respiratory Epithelial Barrier Distress.

Journal: Life (Basel, Switzerland)

Published: May 21, 2026

A four-year journey towards clinical remission and background therapies optimization with benralizumab: A retrospective analysis.

A four-year journey towards clinical remission and background therapies optimization with benralizumab: A retrospective analysis.

Journal: The World Allergy Organization journal

Published: April 08, 2026

Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence.

Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence.

Journal: Current allergy and asthma reports

Published: March 25, 2026

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.

Journal: Biomedicines

Published: February 12, 2026

Investigation of Biomarkers in Allergic Patients with Long COVID.

Investigation of Biomarkers in Allergic Patients with Long COVID.

Journal: Journal of personalized medicine

Published: October 29, 2025

Eosinophilic ascites and eosinophilic gastrointestinal diseases.

Eosinophilic ascites and eosinophilic gastrointestinal diseases.

Journal: European annals of allergy and clinical immunology

Published: September 15, 2025

Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study.

Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study.

Journal: The World Allergy Organization journal

Published: August 28, 2025

The Drop of Allergen Immunotherapy for Respiratory Allergy in Italy: An Assessment of Sales.

The Drop of Allergen Immunotherapy for Respiratory Allergy in Italy: An Assessment of Sales.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: August 08, 2025

Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics.

Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics.

Journal: Biomedicines

Published: August 06, 2025

Showing 1-12 of 112

Last Updated: 09/26/2026